Quick Takeaways
- Melissa B. Epperly has 4 issuer positions tracked on this page.
- Estimated disclosed ownership value: $5,617,835.
- Recent insider filing activity is available below.
- Info
- Insider Ownership
Insider Trading & Ownership of Melissa B. Epperly
- Location
- Philadelphia, PA
- Summary
- The estimated net worth of Melissa B. Epperly is at least $5,617,835 dollars as of 18 Mar 2026. Melissa B. Epperly is the Chief Financial Officer of Zentalis Pharmaceuticals, Inc. and owns shares of Zentalis Pharmaceuticals, Inc. (ZNTL) stock worth about $5.16M. Melissa B. Epperly is the Director of Roivant Sciences Ltd. and owns shares of Roivant Sciences Ltd. (ROIV) stock worth about $453.3K.
- Signature
- By: /s/ Jo Chen, as Attorney-in-Fact for Melissa B. Epperly
- All Insider Reports
- All Insider Reports
Follow Filing Activity
Follow Melissa B. Epperly and return when a new Insider Trading filing appears.
This tracks SEC filing changes for this page using existing product update flows.
What Changed
- Largest disclosed position: Zentalis Pharmaceuticals, Inc. ($5,164,577).
- Past-year value change for that position: .
Why This Matters
- This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
- You can cross-check role, issuer, and filing chronology directly against the SEC source.
Official SEC Source
Filed on Form 4
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
See Original FilingOwnership of Melissa B. Epperly
| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| ZNTL | Zentalis Pharmaceuticals, Inc. | Chief Financial Officer | $5,164,577 | 12 Feb 2024 | ||
| ROIV | Roivant Sciences Ltd. | Director | $453,258 | -$1,200,573 | -73% | 16 Mar 2026 |
| KNTE | Kinnate Biopharma Inc. | Director | 03 Apr 2024 | |||
| NAUT | Nautilus Biotechnology, Inc. | Director | 23 Jun 2025 |
Insider Transactions Reported by Melissa B. Epperly:
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.